Related references
Note: Only part of the references are listed.Novel signaling pathways regulate SARS-CoV and SARS-CoV-2 infectious disease
Li-Chin Cheng et al.
MEDICINE (2021)
Serum levels of the IgA isotype switch factor TGF-β1 are elevated in patients with COVID-19
Er-yi Wang et al.
FEBS LETTERS (2021)
Investigation into molecular mechanisms and high-frequency core TCM for pulmonary fibrosis secondary to COVID-19 based on network pharmacology and data mining
Mei-Xiang Yu et al.
ANNALS OF PALLIATIVE MEDICINE (2021)
Transforming growth factor-beta in tissue fibrosis
Nikolaos G. Frangogiannis
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
SARS-CoV-2: a storm is raging
Savannah F. Pedersen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Pulmonary fibrosis in critical ill patients recovered from COVID-19 pneumonia: Preliminary experience
Yu Fang et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2020)
Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study
Peixun Zhang et al.
BONE RESEARCH (2020)
Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance
[Anonymous]
PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE (2020)
THE TNF FAMILY OF LIGANDS AND RECEPTORS: COMMUNICATION MODULES IN THE IMMUNE SYSTEM AND BEYOND
Catherine Dostert et al.
PHYSIOLOGICAL REVIEWS (2019)
Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis
Chang-Min Lee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2014)
Amphiregulin, an Epidermal Growth Factor Receptor Ligand, Plays an Essential Role in the Pathogenesis of Transforming Growth Factor-β-induced Pulmonary Fibrosis
Yang Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Soluble TNF Mediates the Transition from Pulmonary Inflammation to Fibrosis
Nikos Oikonomou et al.
PLOS ONE (2006)